A second dose of an investigational nasal spray formulation of mebufotenin benzoate -- a tryptamine psychedelic -- offered ...

On September 25, 2025, Anebulo announced the first subjects dosed in a Phase 1 single ascending dose ("SAD") study of an intravenous (IV) formulation of its lead drug candidate selonabant. Selonabant ...

There’s a new way to treat alcoholism — and it’s as easy as popping a candy. Clutch, from Oar Health, is said to be the first ...

We have made significant progress towards our goal of providing the first emergency antidote for acute cannabis-induced toxicity in children,” ...

Every year, people around the world take an astonishing 3.8 trillion doses of medicine. Most of these medicines are swallowed ...

Gratitude and nature each enhance well-being. Together, they create a powerful, science-backed path to restoring attention, ...

Prosper Junior Bakiny has positions in Eli Lilly, Novo Nordisk, and Viking Therapeutics. The Motley Fool has positions in and ...

The FDA has lifted black box warnings on hormone replacement therapy, paving the way for safer options that could help ...

The Food and Drug Administration announced Monday it would remove the black box warning on hormone replacement therapy for ...

A 12 mg dose of BPL-003 (mebufotenin benzoate nasal spray) administered eight weeks after an initial 12 mg, 8 mg or 0.3 mg ...